TickerFacts.

Processa Pharmaceuticals, Inc. (PCSA): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.2K
Year ended 2024-12-31
-11.5%
10-year compound annual growth
$334.3K2012-12-31: $334.3K2013-12-31: $27.7K2014-12-31: $11.0K2015-12-31: $1.4K2016-12-31: $23.8K2017-12-31: $20.6K2023-12-31: $2.8K2024-12-31: $3.2K$3.2K
2012-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$3.2K+16.9%2025-03-20, From 2024-01-01
2023-12-31$2.8Kn/a2025-03-20, From 2023-01-01
No annual figure between 2017-12-31 and 2023-12-31.
2017-12-31$20.6K-13.3%2019-04-08, From 2017-01-01
2016-12-31$23.8Kn/m2018-04-16, From 2016-01-01
2015-12-31$1.4K-87.3%2017-09-25, From 2015-01-01
2014-12-31$11.0K-60.2%2017-06-19, From 2014-01-01
2013-12-31$27.7K-91.7%2015-04-14, From 2013-01-01
2012-12-31$334.3Kn/a2014-03-27, From 2012-01-01